Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
Background: Macular edema (ME) treatment has benefited from the recent intravitreal pharmacotherapy development of an intravitreal implant of dexamethasone (Ozurdex®, Allergan, Irvine, Calif., USA). However, its efficiency has never been illustrated beyond 3 injections. Case Presentation: We report...
Main Authors: | Frederic Matonti, Louis Hoffart, Christophe Baeteman, Danièle Denis |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2012-10-01
|
Series: | Case Reports in Ophthalmology |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/343643 |
Similar Items
-
Combination of Ranibizumab and Dexamethasone intravitreal implant for macular edema secondary to retinal vein occlusion
by: Zhu Jing, et al.
Published: (2024-01-01) -
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
by: Jazmín Baca Moreno, et al.
Published: (2024-03-01) -
Efficacy of Intravitreal Dexamethasone Implant in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion and Resistant to Intravitreal Ranibizumab Injection
by: Ayşe Ergin, et al.
Published: (2022-12-01) -
Comparison of the Safety and Efficacy of Intravitreal Ranibizumab with or without Laser Photocoagulation Versus Dexamethasone Intravitreal Implant with or without Laser Photocoagulation for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Kumar Prashant, et al.
Published: (2019-06-01) -
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
by: Eun Young Choi, et al.
Published: (2019-04-01)